Patents Assigned to Quantovir AB
  • Method and kit for quantitative and qualitative determination of human papillomavirus
    Publication number: 20070037137
    Abstract: The present invention relates to a method and kit for quantitative and qualitative determination of human papillomavirus, HPV, in a sample. More precisely, for quantitative and qualitative determination of oncogenic HPV to predict the risk of HPV infection resulting in cervical carcinoma. The method and kit enable simultaneous measurement of several oncogenic HPV types.
    Type: Application
    Filed: October 1, 2003
    Publication date: February 15, 2007
    Applicant: QUANTOVIR AB
    Inventors: Ulf Gyllensten, Martin Moberg
  • Method and kit for early cancer prediction
    Patent number: 6420106
    Abstract: The present invention is within the field of early cancer prediction. More closely, the invention relates to a method and kit for predicting virus-associated cervical cancer in a human subject. In the method the amount of viral nucleic acid is normalized in relation to the amount of sample from a human subject. Using specific primers and probes in a DNA amplification kit of the invention, a value of relative viral load is obtained which enables prediction of risk of cervical cancer several years before any symptoms thereof.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: July 16, 2002
    Assignee: Quantovir AB
    Inventors: Ulf Gyllensten, Agnetha Josefsson, Patrik Magnusson